Centre for Commercialization of Regenerative Medicine
Biotechnology Company
Business Contact
Contact Information
Closed now8:30 a.m. – 5:00 p.m.
- Monday8:30 a.m. – 5:00 p.m.
- Tuesday8:30 a.m. – 5:00 p.m.
- Wednesday8:30 a.m. – 5:00 p.m.
- Thursday8:30 a.m. – 5:00 p.m.
- Friday8:30 a.m. – 5:00 p.m.
- SaturdayClosed
- SundayClosed
Business Description
Michael May is the primary contact at Centre for Commercialization of Regenerative Medicine.
Industry: Professional Services » Biotechnology Company
- Biotechnology Company
Questions & Answers
1.How long has Centre for Commercialization of Regenerative Medicine been in business?
Centre for Commercialization of Regenerative Medicine has been in business for 15 years.
2.What is Centre for Commercialization of Regenerative Medicine's phone number?
Centre for Commercialization of Regenerative Medicine's phone number is (416) 978-3751.
3.Where is Centre for Commercialization of Regenerative Medicine located?
Centre for Commercialization of Regenerative Medicine is located at 1002, 661 University Ave, Toronto, ON M5G 1M1, Canada, Ontario. Get Directions.
4.What are Centre for Commercialization of Regenerative Medicine's hours?
Centre for Commercialization of Regenerative Medicine is open during the following hours: weekdays: 8:30 a.m. – 5:00 p.m.; weekends: Closed.
5.Who is the primary contact at Centre for Commercialization of Regenerative Medicine?
The primary contact at Centre for Commercialization of Regenerative Medicine is Michael May (CEO).
6.What is Centre for Commercialization of Regenerative Medicine's website?
Centre for Commercialization of Regenerative Medicine's website is www.ccrm.ca.
7.How big is Centre for Commercialization of Regenerative Medicine?
Centre for Commercialization of Regenerative Medicine employs approximately 135 people.
8.How many employees does Centre for Commercialization of Regenerative Medicine have?
Centre for Commercialization of Regenerative Medicine has approximately 135 employees.
0 Reviews
Be the first to write a review for Centre for Commercialization of Regenerative Medicine.